Envases Venezolanos, S.A. (CCSE:ENV)

Regulus Therapeutics Cash Flow Statement

Financials in millions VES. Fiscal year is September - August.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020	Aug 31, 2019
Net Income	103.58	146.75	8.48	6.04	-1.53
Depreciation & Amortization	27.21	26.09	33.89	2.54	0.65
Other Operating Activities	266.33	124.51	8.66	10.44	0.03
Change in Accounts Receivable	37.05	128.09	-23.52	-4.3	-0.04
Change in Inventory	-49.88	-211.52	-29.3	1.66	-0.13
Change in Accounts Payable	50.78	-25	-0.96	0.67	0.14
Change in Income Taxes	-13.5	-11.75	-1.75	3.06	-0.03
Change in Other Net Operating Assets	-61.37	-60.55	-27.94	-17.14	0.38
Operating Cash Flow	74.44	54.75	-32.43	2.98	-0.56
Operating Cash Flow Growth	35.98%	-	-	-	-
Investment in Securities	-93.02	-34.24	13.54	1.12	0.55
Investing Cash Flow	-93.02	-34.24	13.54	1.12	0.55
Short-Term Debt Repaid	-	-	-	-	-0.09
Long-Term Debt Repaid	-	-	-	-0.17	-0
Total Debt Repaid	-	-	-	-0.17	-0.09
Net Debt Issued (Repaid)	-	-	-	-0.17	-0.09
Common Dividends Paid	-1	-5.69	-	-	-0.01
Other Financing Activities	-	-	1.62	0	-
Financing Cash Flow	-1	-5.69	1.62	-0.17	-0.1
Net Cash Flow	-19.58	14.81	-17.27	3.94	-0.1
Free Cash Flow	74.44	54.75	-32.43	2.98	-0.56
Free Cash Flow Growth	35.98%	-	-	-	-
Free Cash Flow Margin	7.80%	4.32%	-13.44%	4.22%	-12.05%
Free Cash Flow Per Share	0.59	0.42	-0.23	0.02	-
Cash Interest Paid	-	-	0	0.45	0.02
Cash Income Tax Paid	8.87	13.12	1.59	0	0.01
Levered Free Cash Flow	324.26	-143.12	25.39	9.91	-
Unlevered Free Cash Flow	325.84	-141.38	25.41	9.92	-
Change in Net Working Capital	-154.58	392.77	56.59	2.35	-

Updated Oct 19, 2012. Source: S&P Global Market Intelligence. Standard template. Financial Sources.